Thank you for sharing!

Your article was successfully shared with the contacts you provided.

Executives of pharmaceutical, biotechnology and medical device companies must know and abide by myriad statutes and regulations. Laws governing the pricing, marketing and selling of health care products abound. Many carry stiff criminal penalties. And the federal government has aggressively investigated health care companies for alleged violations.

Not infrequently, a corporate entity has chosen to plead guilty to criminal violations rather than to risk conviction and debarment, which would prevent it from doing business with government agencies and bar others from receiving government reimbursement for using the company’s products. But the individual executives have long taken some comfort in the fact that most criminal laws only punish those who act with criminal intent.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]

Reprints & Licensing
Mentioned in a Law.com story?

License our industry-leading legal content to extend your thought leadership and build your brand.


ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.